探索长非编码RNA作为瘤铁灭的调节剂:进展和挑战
Gang Li1, Bing Wang1, Lisha Ye1
1Institute of Special Environmental Medicine, Nantong University, Nantong, China.
Cancer science
|April 3, 2025
概括
长非编码RNAs (lncRNAs) 在癌症中至关重要,并调节细胞死亡过程ferroptosis. 向lncRNAs提供了一种有前途的策略,通过调节铁亡来增强癌症疗法.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 生物化学 生物化学
背景情况:
- 长非编码RNAs (lncRNAs) 是基因表达和生物过程的关键调节者.
- lncRNAs越来越多地被认为对癌症的发展,进展和治疗耐药性的作用.
- 铁,一种依赖于铁的细胞死亡,是一种新兴的癌症治疗策略.
研究的目的:
- 审查目前对lncRNAs在瘤铁亡中的作用的理解.
- 突出 lncRNAs 在癌细胞内的铁代谢中的参与.
- 探索 lncRNAs 作为联合癌症治疗中的治疗点的潜力.
主要方法:
- 关于 lncRNAs 和癌症中的铁亡的最新研究的文献综述.
- 对研究铁代谢的lncRNA介导调节的研究进行分析.
- 综合了关于lncRNAs在基于ferroptosis的癌症治疗中的治疗影响的发现.
主要成果:
- lncRNAs显著影响固体瘤中的铁亡,影响侵袭,转移和扩散.
- 通过lncRNAs调节铁亡,可以抑制瘤生长并克服化学抵抗.
- lncRNAs在调节铁平衡中发挥作用,这是铁亡的一个关键组成部分.
结论:
- lncRNAs是癌症中ferroptosis的关键调解者.
- 针对涉及铁亡的lncRNAs提供了一个新的治疗途径.
- 将基于lncRNA的策略与ferroptosis诱导相结合可能会提高癌症治疗的疗效.
更多相关视频
11:11Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
7.9K
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.7K
相关概念视频
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
MicroRNAs
2.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
The Nucleolus
8.6K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K
Formation of Muscle Fibers from Myoblasts
4.1K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
4.1K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
